A phase IIIb study of ledipasvir/sofosbuvir fixed-dose combination tablet in treatment-naïve and treatment-experienced Korean patients chronically infected with genotype 1 hepatitis C virus

Young Suk Lim, Sang Hoon Ahn, Kwan Sik Lee, Seung Woon Paik, Youn Jae Lee, Sook Hyang Jeong, Ju Hyun Kim, Seung Kew Yoon, Hyung Joon Yim, Won Young Tak, Sang Young Han, Jenny C. Yang, Hongmei Mo, Kimberly L. Garrison, Bing Gao, Steven J. Knox, Phillip S. Pang, Yoon Jun Kim, Kwan Soo Byun, Young Seok KimJeong Heo, Kwang Hyub Han

Research output: Contribution to journalArticlepeer-review

15 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A phase IIIb study of ledipasvir/sofosbuvir fixed-dose combination tablet in treatment-naïve and treatment-experienced Korean patients chronically infected with genotype 1 hepatitis C virus'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science